It’s Melanoma Monday, and TDD Editorial Advisory Board Member Vishal Patel, MD, an Associate Professor of Dermatology at the GW School of Medicine & Health Sciences and the Director of the Cutaneous Oncology Program at the GW Cancer Center in Washington, DC, highlights recent advances in diagnosing and treating melanoma, including the approval of the DermaSensor device for detection in the primary care setting and new evidence that neoadjuvant immunotherapy before surgery improves outcome for patients with metastatic disease.
